Combination vaccines & Gavi policy (IHEA 2025 Pre-Congress Day 2)

Home > Combination vaccines & Gavi policy (IHEA 2025 Pre-Congress Day 2)

Sunday, July 20, 13:15 – 14:30

MARIA VERYKIOU, Gavi policy team

mverykiou@gavi.org

Gavi’s thinking for the 6.0 strategy

Maria Verykiou joined Gavi the Vaccine Alliance as a Policy Manager in 2023. She is currently supporting the development of Gavi’s 6.0 Partnerships approach, and has previously led the evaluation of vaccine candidates under the Vaccine Investment Strategy 2024, the review of Gavi’s prioritization mechanism and funding policies. Her background is in health economics and has previously worked in research at Bocconi University, Italy.

MERCY MVUNDURA, PATH

mmvundura@path.org

Exploring the value of combination vaccines

Mercy Mvundura, PhD, works as a health economics technical advisor at PATH, based in Seattle USA. She has over 15 years of experience designing and conducting economic evaluations of health care programs, interventions, and technologies. Her current and past work involves leading the design and conduct of cost of delivery and cost-effectiveness studies aimed at evaluating immunization program activities and interventions. She also conducts economic evaluations of technologies and interventions focused on maternal and child health and non-communicable diseases.

IHEA 2025

Take a look at the agenda, speakers, and presentations by clicking the button below.